These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18032008)

  • 1. Protective mechanisms of IVIG.
    Clynes R
    Curr Opin Immunol; 2007 Dec; 19(6):646-51. PubMed ID: 18032008
    [No Abstract]   [Full Text] [Related]  

  • 2. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
    Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
    Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
    Crow AR; Lazarus AH
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIG therapy: interfering with interferon-gamma.
    Clynes R
    Immunity; 2007 Jan; 26(1):4-6. PubMed ID: 17241954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
    Samuelsson A; Towers TL; Ravetch JV
    Science; 2001 Jan; 291(5503):484-6. PubMed ID: 11161202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS; Sun DS; Lien TS; Chang HH
    Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
    Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
    Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology. Giving inhibitory receptors a boost.
    Lin SY; Kinet JP
    Science; 2001 Jan; 291(5503):445-6. PubMed ID: 11228143
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R; Lemieux R; Tremblay T; St-Amour I
    Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.
    Sehgal K; Guo X; Koduru S; Shah A; Lin A; Yan X; Dhodapkar KM
    Sci Transl Med; 2013 Jul; 5(193):193ra89. PubMed ID: 23843450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.
    Bierling P; Godeau B
    Hum Immunol; 2005 Apr; 66(4):387-94. PubMed ID: 15866702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complexes as therapy for autoimmunity.
    Clynes R
    J Clin Invest; 2005 Jan; 115(1):25-7. PubMed ID: 15630438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.